A taxifolin-zinc nanozyme with SOD-like activity attenuates oxidative-stress-induced senescence and extends lifespan in C. elegans.
Key claim: A taxifolin–zinc nanozyme with SOD-like activity suppressed oxidative-stress-induced senescence in cells and extended lifespan and healthspan indicators in C. elegans.
Abstract
Oxidative stress is a key driver of cellular senescence and functional decline. However, many natural polyphenols have limited bioavailability because they are difficult to formulate into stable systems. Here, we report a polyphenol-metal coordination nanozyme prepared by coordinating zinc with taxifolin and using L-arginine to regulate assembly. The resulting Tax-Zn nanozyme formed a well-dispersed nanoscale system with an average hydrodynamic diameter of 57.53 nm. Functionally, the nanozyme exhibited broad antioxidant capacity in several assays and showed slightly stronger activity than Tax in selected assays. In MEFs, Tax-Zn nanozyme showed low cytotoxicity and markedly suppressed intracellular ROS under HOchallenge, accompanied by improved mitochondrial function and attenuation of senescence-associated phenotypes. In C. elegans, Tax-Zn nanozyme extended lifespan and improved healthspan-related indicators. Collectively, these results support the nanozyme as a natural-product-derived coordination platform that mitigates oxidative-stress-related senescence phenotypes and supports the development of antioxidant nano-formulations.
Why this matters
The finding is one more entry in the long list of polyphenol-plus-antioxidant-chemistry formulations that extend C. elegans lifespan and reduce oxidative senescence in cells — a space where translation to mammals, let alone humans, has repeatedly stalled. Its distinctive angle is the nanozyme format: taxifolin–zinc coordination gives catalytic SOD-like activity rather than stoichiometric scavenging, which could matter if the mammalian-translation failures of flavonoid antioxidants are partly dose/half-life problems rather than target problems. Still fully preclinical, and nothing here distinguishes catalytic from conventional antioxidant activity at the organismal level.